Загрузка...
Proteomics and peptidomics: moving toward precision medicine in urological malignancies
Urological malignancies are a major cause of morbidity and mortality worldwide. Advances in early detection, diagnosis, prognosis and prediction of treatment response can significantly improve patient care. Proteomic and peptidomic profiling studies are at the centre of kidney, prostate and bladder...
Сохранить в:
| Опубликовано в: : | Oncotarget |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Impact Journals LLC
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5239567/ https://ncbi.nlm.nih.gov/pubmed/27119500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8931 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|